Ashvattha Therapeutics Shares Positive Interim Phase 2 Results for SubQ MGB in DME, AMD阿什瓦塔治疗公司分享了SubQ MGB在DME、AMD中的积极中期2期结果July 03, 20252025年7月3日Ashvattha Therapeutics has announced promising interim...
Source LinkAshvattha Therapeutics Shares Positive Interim Phase 2 Results for SubQ MGB in DME, AMD阿什瓦塔治疗公司分享了SubQ MGB在DME、AMD中的积极中期2期结果July 03, 20252025年7月3日Ashvattha Therapeutics has announced promising interim...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.